NCT02241265 Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
| NCT ID | NCT02241265 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2014-02 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2014-02 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.
Eligibility Criteria
Inclusion Criteria: * \>18 years of age * severe asthma diagnosis * decreased FEV1 Exclusion Criteria: * \< 18 years of age
Contact & Investigator
Brent Brown, MD
PRINCIPAL INVESTIGATOR
OUHSC
Frequently Asked Questions
Who can join the NCT02241265 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02241265 currently recruiting?
Yes, NCT02241265 is actively recruiting participants. Contact the research team at brent-brown@ouhsc.edu for enrollment information.
Where is the NCT02241265 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT02241265 clinical trial?
NCT02241265 is sponsored by University of Oklahoma. The principal investigator is Brent Brown, MD at OUHSC. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.